tiprankstipranks
Advertisement
Advertisement
Immunotech Biopharm Widens Annual Loss as Cancer Cell Therapies Advance in China
PremiumCompany AnnouncementsImmunotech Biopharm Widens Annual Loss as Cancer Cell Therapies Advance in China
2M ago
Immunotech Biopharm Tightens Audit Committee Rules to Bolster Governance
Premium
Company Announcements
Immunotech Biopharm Tightens Audit Committee Rules to Bolster Governance
2M ago
Immunotech Biopharm Updates Remuneration Committee Terms to Strengthen Governance
Premium
Company Announcements
Immunotech Biopharm Updates Remuneration Committee Terms to Strengthen Governance
2M ago
Immunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
PremiumCompany AnnouncementsImmunotech Biopharm Subsidiary Signs RMB9.75 Million Cell Therapy Service Deal With Tasly
4M ago
Immunotech Biopharm Moves to Refinance 2023 Convertible Bonds via New Issue
Premium
Company Announcements
Immunotech Biopharm Moves to Refinance 2023 Convertible Bonds via New Issue
4M ago
Immunotech Biopharm Ltd Engages in Strategic Financial Investment
Premium
Company Announcements
Immunotech Biopharm Ltd Engages in Strategic Financial Investment
5M ago
Immunotech Biopharm Ltd Announces Trading Halt Pending Rights Issue Announcement
PremiumCompany AnnouncementsImmunotech Biopharm Ltd Announces Trading Halt Pending Rights Issue Announcement
8M ago
Immunotech Biopharm Ltd Reports Increased Losses in H1 2025
Premium
Company Announcements
Immunotech Biopharm Ltd Reports Increased Losses in H1 2025
9M ago
Immunotech Biopharm Ltd Schedules Board Meeting for Interim Results
Premium
Company Announcements
Immunotech Biopharm Ltd Schedules Board Meeting for Interim Results
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100